Heather Zhang
About Heather Zhang
Heather Zhang is the Director of Clinical Pharmacology at BeiGene with extensive experience in drug metabolism, bioanalytical methods, and clinical study design.
Title and Current Role
Heather Zhang serves as the Director of Clinical Pharmacology at BeiGene. In this role, she oversees clinical pharmacology strategies and operations, contributing to drug development and advancing pharmaceutical sciences within the company.
Professional Experience at Novartis
Heather Zhang worked at Novartis Institutes for BioMedical Research (NIBR) as a Senior Investigator (Associate Director) from 2017 to 2018. During her tenure, she managed pharmacokinetics and pharmacodynamics (PK-PD) and pharmacokinetics and absorption, distribution, metabolism, and excretion (PK-ADME) of hepatitis B virus (HBV) and tropical disease projects at both preclinical and clinical stages.
Career at Gilead Sciences
Heather Zhang served as a Senior Clinical Pharmacologist at Gilead Sciences from 2011 to 2017. She was the clinical pharmacology lead for multiple drugs and clinical candidates in the cardiovascular and HIV fields. Her work involved extensive experience in drafting multiple Investigational New Drug (IND) applications, supplemental New Drug Applications (sNDAs), and one New Drug Application (NDA).
Early Professional Background
Heather Zhang began her career as a Scientist II at Pharmacia-Sugen from 1998 to 2003. She then worked as a Staff Scientist at Elan Pharmaceuticals for eight years until 2011. These roles forged her expertise in drug metabolism, bioanalytical methods, drug-drug interaction assays, and human dose projection.
Educational Background
Heather Zhang achieved her Ph.D. in Pharmacy from Purdue University, where she studied from 1993 to 1998. She also earned an M.Sc. in Analytical Chemistry from Memorial University of Newfoundland, completing her studies there from 1990 to 1993.